Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy (Q47378087)

15 January 2018

title

Molecular weight of low molecular weight heparins by 13C nuclear magnetic resonance spectroscopy (English)

1 reference

15 January 2018

2

Linhardt RJ

1 reference

15 January 2018

Desai UR

1

1 reference

15 January 2018

publication date

1 March 1994

1 reference

15 January 2018

published in

Carbohydrate Research

1 reference

15 January 2018

volume

255

1 reference

15 January 2018

page(s)

193-212

1 reference

15 January 2018

Mapping and quantification of the major oligosaccharide components of heparin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

The molecular-weight-dependence of the anti-coagulant activity of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Oligosaccharide mapping of low molecular weight heparins: structure and activity differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Physicochemical studies of fractionated bovine heparin. I. Some dilute solution properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Physicochemical studies of fractionated bovine heparin. II. Viscosity as a function of ionic strength

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Physico-chemical studies of fractionated bovine heparin. V. Some low-angle x-ray scattering data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Studies on the Conformation of Heparin by1H and13C NMR Spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Structure of heparin-derived tetrasaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

α-l-iduronate ring conformations in heparin and heparin derivatives. 13C Nuclear-magnetic-resonance analysis and titration data for variously desulphated and periodate-oxidized heparins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

One- and two-dimensional 13C-n.m.r. characterization of two series of oligosaccharides derived from porcine intestinal mucosal heparin by degradation with heparinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Analysis of glycosaminoglycan-derived oligosaccharides using fast-atom-bombardment mass-spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Examination of the substrate specificity of heparin and heparan sulfate lyases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Physicochemical characterization of the First World Health Organization International Standard for low molecular weight heparin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

Structure and biological activity of heparin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6215%2800%2990979-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-6215(00)90979-0

1 reference

15 January 2018

1 reference

15 January 2018